Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
16.2M
-
Shares change
-
+212K
-
Total reported value, excl. options
-
$204M
-
Value change
-
+$2.82M
-
Number of buys
-
25
-
Number of sells
-
-34
-
Price
-
$12.59
Significant Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q3 2020
75 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q3 2020.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2M shares
of 50M outstanding shares and own 32.4% of the company stock.
Largest 10 shareholders include FMR LLC (1.74M shares), SV Health Investors, LLC (1.72M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.68M shares), Vivo Capital, LLC (1.48M shares), Ikarian Capital, LLC (1.24M shares), BlackRock Inc. (915K shares), PICTET ASSET MANAGEMENT LTD (854K shares), WELLINGTON MANAGEMENT GROUP LLP (764K shares), VANGUARD GROUP INC (559K shares), and Opaleye Management Inc. (470K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.